Stay updated with breaking news from Gate Neurosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Core royalty platform on track; received GSK royalties of $69.6 million for fourth quarter Achieved net product revenues of $19.7 million for the fourth quarter of 2023 representing 35% year on...
Gate Neurosciences opened a lab in Evanston, expanding their research and development of next-generation neuroscience therapies, according to the company’s May 3 news release. The Indiana-based biotech startup uses precision medicine to develop drugs aimed at treating nervous system disorders, including depression. The lab, based at NorthShore Evanston Hospital, will expand the company’s capabilities for...
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
Received GSK royalties of $60.3 million, net product revenues of $11.5 million and license revenue of $8.0 million in the first quarter of 2023Repurchased $40.3 million of common stock and paid off $96.2 million of 2023 convertible notesBURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” o...
Received GSK royalties of $60.3 million, net product revenues of $11.5 million and license revenue of $8.0 million in the first quarter of 2023 Repurchased $40.3 million of common stock and paid... | May 9, 2023